期刊文献+

胸部单中心型巨淋巴结增生症3例^(18)F-FDG符合线路显像表现及文献复习 被引量:4

The ^(18)F-FDG coincidence SPECT imaging findings of chest unicentric castleman's disease
在线阅读 下载PDF
导出
摘要 目的探讨胸部单中心型巨淋巴结增生症18F-FDG符合线路SPECT/CT显像表现。方法回顾分析经手术病理证实的3例单中心型巨淋巴结增生症患者的影像资料,3例患者均行CT平扫、增强扫描及18 F-FDG符合线路SPECT/CT显像。结果肿块位于前纵隔1例,右中纵隔1例,左上肺门1例,类圆形1例,分叶状2例,伴有斑点状钙化2例,肿块最大径4.4~5.9cm;增强扫描明显均匀强化2例,不均匀强化1例;1例患者伴有单侧胸腔积液。肿块放射性分布不均匀2例,大致均匀1例;目测分级2级1例,3级1例,4级1例,T/Nmax值4.5~7.2。结论单中心型巨淋巴结增生症表现为明显强化的肿块,葡萄糖代谢不同程度的增高,葡糖糖代谢明显增高的病变需要与恶性病变鉴别。 Objective To investigate the 18F-FDG coincidence SPECT/CT imaging findings of unicentric Castleman's dis- ease. Methods We retrospectively reviewed the imagine findings of 3 patients with histopathologically proved chest uni- centric Castleman's disease. All the 3 patients were taken unenhanced CT scan, enhanced CT scan, and 18F-FDG coinci- dence SPECT/CT. Results The tumors were located at anterior mediastinum (n= 1), right middle mediastinum (n= 1), or left hilum (n=1). The shape was oval (n=l)or lobulated (n=2), ranging 4. 445.9 cm in diameter. Punctate calcifi- cation within the tumor was seen in 2 patient. 2 tumors showed obvious homogeneous enhancement after the administration of contrast medium, while 1 tumor showed inhomogeneous enhancement. Unilateral pleural effusion was seen in 1 patient. All 3 tumors showed increased uptake of 18F-FDG. One tumor was visual grade as 2, 3 eack and 4. T/Nmax value ranged from 4.5 to 7.2. Conclusion Unicentric Castleman's disease showed obvious enhancement on CT and various degrees of increaseed uptake of 18F-FDG, which should be differentiated from malignant tumors.
出处 《医学影像学杂志》 2015年第7期1174-1177,共4页 Journal of Medical Imaging
关键词 巨淋巴结增生症 胸部 体层摄影术 X线计算机 18氟-脱氧葡萄糖 正电子发射型计算机体层显像 Castleman's disease Chest Tomography, X-ray computed 18F-FDG Coincidence SPECT
  • 相关文献

参考文献19

  • 1Shahidi H, Myers JL, Kvale PA. Castleman's disease [J]. Mayo Clin Proc, 1995, 70(10) : 969-977.
  • 2Keller A, Hoehholzer L, Castleman B. Hyaline-vascular and plasma cell types of giant lymph node hyperplasia of the medi- astinumand otherlocations [J]. Cancer, 1972, 29(3): 670- 683.
  • 3Casper C. The aetiology and management of Castleman dis- ease at 50 years., translating pathophysiology to patient care [J]. BrJ Haematol, 2005, 129(1):3-17.
  • 4李佩玲,常妙,刘婷,韩昱晨,王强,赵丽,徐克.巨淋巴结增生症的多层螺旋CT表现[J].中华放射学杂志,2013,47(1):64-67. 被引量:42
  • 5龚民,高志,郑鑫.巨淋巴结增生症的研究进展[J].中华胸心血管外科杂志,2011,27(4):250-251. 被引量:11
  • 6Lee ES, Paeng JC, Park CM, et al. Metabolic characteristics of castleman disease on 18F FDG PET in relation to clinical Implication[J]. ClinNuclMed, 2013,38(5): 339-342.
  • 7付占立,张旭初,范岩,张建华,王荣福.^18F-FDGPET/CT在Castleman病中的临床应用价值[J].中华核医学与分子影像杂志,2013,33(5):332-335. 被引量:15
  • 8Kim DE, Kim ILl, Kim YA. associated Castleman's disease Kaposi's sarcoma herpesvirns- with POEMS syndrome[J]. Muscle Nerve, 2000, 23(3): 436-439.
  • 9El-Osta HE, Kurzrock R. Castleman's disease: from basic mechanisms to molecular therapeutics [J]. Oncologist, 2011, 16(4): 497-511.
  • 10Van Rhee F, Fayad L, Voorhees P, et al. Siltuximab, a no- vel anti interleukin-6 monoclonal antibody, for Castleman's disease [J].J Clin Oncol, 2010, 28(23): 3701-3708.

二级参考文献61

  • 1武淑兰,李竞贤,陈宏民,聂立功,王颖,许广润.Castleman病八例的临床病理学研究[J].中华内科杂志,1994,33(3):179-182. 被引量:33
  • 2刘德军,冯彦林,贺小红,袁建伟.Castleman病^18F-FDG PET/CT显像一例[J].中华核医学杂志,2005,25(6):380-380. 被引量:6
  • 3周乃康,王波,梁朝阳,刘阳,柳曦,田晓东,刘颖.胸内Castleman病的外科治疗[J].解放军医学杂志,2006,31(2):159-161. 被引量:3
  • 4周良平,张蓓,王佩华,关玉宝,彭卫军,杨文涛,周康荣.腹、盆部巨大淋巴结增生的影像学表现[J].中华放射学杂志,2006,40(5):522-526. 被引量:51
  • 5Castleman B,Iverson L,Menendez VP.Localized mediastinal lymphnodehyperplasia resembling thymoma.Cancer,1956,9:822-830.
  • 6Keller A,Hochholzer L,Castleman B.Hyaline-vascular and plasmacell types of giant lymph node hyperplasia of the mediastinum and otherlocations.Cancer,1972,29:670-683.
  • 7Singh M,Saroha V,Gupta P,et al.Hyaline vascular Castleman disease relapsing as T cell rich B cell lymphoma with paraneoplastic pemphigus.J Clin Pathol,2011,64:93-94.
  • 8Seo HY,Kim EB,Kim JW,et al.Complete remission in a patient with human herpes virus-8 negative multicentric Castleman disease using CHOP chemotherapy.Cancer Res Treat,2009,41:104-107.
  • 9Sato N,Kondo S,Saito K,et al.Hyaline vascular-type castleman's disease in the hepatoduodenal ligament:report of a case.Surg Today,2006,36:647-650.
  • 10Luppi M,Barozzi P,Maiorana A,et al.Human herpevirus-8 DNA sequences in human immunodeficiency virus-negative angioimmuno-blastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity.Blood,1996,87:3903-3909.

共引文献89

同被引文献27

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部